Clinical Trial Update: MDMA-assisted Massed Prolonged Exposure for PTSD [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating MDMA-assisted massed prolonged exposure therapy for post-traumatic stress disorder is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder

Drugs mentioned

• MDMA (3,4-methylenedioxymethamphetamine)

Snippet

Sponsor: Healing Breakthrough | Conditions: Post-Traumatic Stress Disorder | Phase 3 | Status: RECRUITING